The Most Consequential Eight Hours in Macro This Year

The 2-year Treasury yield hit 4.25% on Monday, its highest level since February 2025, per Bloomberg. That single number is doing a lot of work right now: it is simultaneously a verdict on the Iran escalation, a constraint on equity valuations, and the setup for what may be the most data-dense single morning the market has faced all year.

Monday's session was driven by one event. President Trump reinstated a blockade on Iranian shipping through the Strait of Hormuz, per CNBC, which pushed oil prices sharply higher and sent Treasury yields to multi-month peaks across the curve. The 5-year hit 4.35% and the 10-year rose to 4.60%, per Bloomberg. The S&P 500 fell 0.79% to 7,515.34, the Nasdaq dropped 1.55%, and the Dow shed 138 points, per CNBC.

That was Monday. Tuesday morning is a different problem entirely.

The BLS released June CPI at 8:30 a.m. ET, the last major inflation print before the July 29 FOMC meeting. Simultaneously, JPMorgan Chase, Goldman Sachs, Bank of America, Citigroup, and Wells Fargo all reported Q2 earnings before the bell, per CNBC. And at 10 a.m., Fed Chair Kevin Warsh delivered his inaugural congressional testimony.

The macro question this creates is not simply "was CPI hot or cold?" It is whether the market can hold two contradictory narratives at once: a geopolitical oil shock that is inherently inflationary, and a banking sector that may be reporting the strongest quarter in years. Per CNBC, investment banking revenue is expected to jump roughly 26% year-over-year and trading revenue roughly 14%, with Goldman and Morgan Stanley seen as primary beneficiaries of SpaceX IPO fee flows.

The Fed's position makes this harder to read. At its June 17 meeting, the Fed held the federal funds rate at 3.50% to 3.75%, per the Federal Reserve's official press release. Nine of 18 officials penciled in at least one rate hike in 2026, and markets are currently pricing in one additional hike before year-end, per the Federal Reserve. An oil-driven CPI surprise does not give the Fed room to pivot. It gives them cover to stay restrictive longer than the equity market has priced.

The consensus coming into this week was that the rate path was roughly known. It is not. Warsh's testimony is the first real signal of how the new Fed chair frames the inflation-versus-growth tradeoff, and the market has no prior testimony to anchor expectations against.

The bull case is that the Iran shock is a supply disruption, not a demand signal, and that the banking earnings confirm the underlying economy is healthy enough to absorb it. If Q2 results show strong net interest income alongside the investment banking surge, the narrative becomes: rates are high, but so are earnings. That is a tolerable environment for equities, particularly for financials and quality compounders with pricing power. A Warsh testimony that sounds measured rather than hawkish could reinforce that read.

The bear case is that the market is already stretched at these levels, and the combination of a hot CPI print, a hawkish Warsh, and oil-driven cost pressure is the kind of triple-hit that breaks the "soft landing" consensus. The 10-year at 4.60%, per Bloomberg, is not a trivial headwind for long-duration assets. At that yield level, the discount rate argument against high-multiple growth stocks is not theoretical. It is arithmetic. Pre-market futures were already slipping further on Tuesday, with S&P 500 futures down 0.2% and Nasdaq 100 futures down 0.3%, per Yahoo Finance, before the CPI number even landed.

The honest version of the bear case is simpler: the market has been pricing a rate-cut path that the Fed's own dot plot does not support, and every piece of data that confirms that gap is a small repricing event. Enough small repricing events become a correction.

The ACCE indices reflect this tension without us having made any changes this week. The AI Infrastructure index gained 0.90% on the week, which is notable given Monday's Nasdaq selloff. Holdings like Broadcom, with a 91/100 quality score and 38.9% net margin, and Meta, with a 100/100 quality score and 32.8% net margin, are the kind of businesses that hold up better in a rate-volatile environment than pure-momentum names.

The Biotech Catalysts index fell 3.98%, which is partly a duration story. Biotech valuations are sensitive to discount rates, and a 4.60% 10-year is a genuine headwind for names priced on out-year cash flows. BioMarin, for instance, trades at a significant discount to our 6-model fair value of $124.18 against a current price of $58.89, per our live data, but that gap does not close quickly when rates are moving against you.

The Clean Energy index dropped 2.99%, consistent with the pattern we have seen all year: higher rates compress the capital-intensive, long-duration cash flow profiles that define that sector.

Two things. First, a CPI print that comes in materially below expectations would shift the rate-hike probability calculus quickly and give the equity market room to re-rate. Second, a Warsh testimony that signals the Fed views the Iran oil shock as transitory rather than a reason to tighten further would matter more than any single data point. The trigger to watch is not the number itself but whether the Fed's reaction function has changed under new leadership. That is what today's testimony is actually about.

The next two weeks are the most information-dense stretch of the summer: FOMC on July 29, earnings season in full swing, and a geopolitical backdrop that is not resolving. The market rarely prices all of that correctly in advance.

The full ACCE analysis on every index holding, including 6-model fair values, quality breakdowns, and the live pick tracker, is at acceinvestments.com. Pro research starts at $6/month.